Aurora Cannabis Inc (ACB) is scheduled to announce Q4 2022 earnings on Tuesday, 20 September 2022, after market close. Wallstreet estimates an EPS of $-0.19 and a revenue of $39.05 M in the upcoming results. Aurora Cannabis Inc historically beated the wallstreet estimates 22% of the times.
About Aurora Cannabis Inc
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; herb mills for using CanniMed herbal cannabis products.